SC-61213

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameSC-61213
Drug Alias NameNMT inhibitors (Searle)Cryptococcus therapy (Searle)antifungal (Searle)Candida therapy (Searle)SC-58272 +[6] 
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCandida Albicans InfectionsCryptococcosisMycoses
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesG. D. Searle & Co
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesG. D. Searle & Co
Active IndicationsN/A
Inactive IndicationsCandida Albicans InfectionsCryptococcosisMycoses

Other Information

ATC CodeN/A
Related LinksN/A